scholarly journals A rare case of renal cell carcinoma with hematogenous extension into the right atrium discovered incidentally on echocardiogram

2020 ◽  
Vol 8 (34) ◽  
pp. 52-55
Author(s):  
Ryan Dean ◽  
Ganesh Maniam ◽  
Thien Vo

While hematogenous spread of renal cell carcinoma (RCC) is common, isolated extension into the renal vein and inferior vena cava (IVC) is rare and extension to the right atrium is even less likely. In the case, a 62-year-old Hispanic female was admitted for a suspected inferior myocardial infarction, and her echocardiogram revealed a right atrial mass consistent with the appearance of an atrial myxoma. Following cardiac catheterization, a histopathological examination of the mass revealed a clear cell tumor consistent with metastatic clear cell RCC. Following a CABG with excision of the atrial mas, the CT demonstrated a 5 cm right lower pole renal mass with hilar involvement, as well as filling defects in the IVC extending into the right renal vein; these findings were consistent with RCC tumor thrombus extension into the renal vein, IVC, and right atrium. The radical nephrectomy necessary for tumor removal could not be performed at this hospital, so the patient was discharged to a higher level of care. The incidence rate for RCC with extension into the right atrium is quite low, but clinicians should understand the lethality of RCC warrants immediate clinical investigation upon diagnosis. The increased utilization of sophisticated imaging modalities will likely continue to increase the rate of incidental discovery of such neoplasms, and physicians should keep RCC on the differential when a right atrial mass is discovered incidentally on echocardiogram.

2014 ◽  
Vol 2 (2) ◽  
pp. 65-67
Author(s):  
Arun Subramanian ◽  
Minati Choudhary ◽  
Ujjwal Chowdhary

ABSTRACT Renal cell carcinoma (RCC) has a tendency to invade the renal vein and thereby reach the right heart through inferior vena cava (IVC). This may necessitate a combined surgical procedure usually under cardiopulmonary bypass (CPB). In the following discussion, we shall present a case of right RCC extending into the right atrium. The patient underwent a radical nephrectomy followed by removal of the tumor from right atrium, IVC and hepatic vein under CPB. How to cite this article Subramanian A, Choudhary M, Chowdhary U. Renal Cell Carcinoma presenting as a Right Atrial Mass. J Perioper Echocardiogr 2014;2(2):65-67


2018 ◽  
Vol 36 (2) ◽  
pp. 77-79
Author(s):  
Syed Al Nahian ◽  
Sonjoy Biswas ◽  
Rezaul Hassan ◽  
M Zahid Hasan

Renal cell carcinoma (RCC) is the commonest primary tumor of the kidney which may invade through the renal vein into the inferior vena cava (IVC), and then it can extend intraluminally with subsequent tumor-thrombus formation. Here we report a case involving excision of a primary RCC with tumor-thrombus involving IVC up to right atrium with the use of extracorporeal circulation. Single stage surgical procedure was performed in collaboration with a urological team aiming complete resection of primary tumor, para-aortic lymphadenectomy and removal of IVC thrombus extending to right atrium with the help of cardiopulmonary bypass. After arresting heart, RA was opened and the mass was removed through RA from IVC and hepatic vein level. Abdominal IVC was opened and the entire residual mass was removed from below also small amount of thrombus removed from left renal vein. Postoperative venous doppler showed no residual thrombus in venous system. Histopathology report confirmed papillary renal cell carcinoma. The patient was discharged from hospital in the 12th post-operative day without any complication.J Bangladesh Coll Phys Surg 2018; 36(2): 77-79


Cor et Vasa ◽  
2011 ◽  
Vol 53 (12) ◽  
pp. 751-752
Author(s):  
Jan Dominik ◽  
Petr Morávek ◽  
Pavel Žáček ◽  
Miroslav Brtko

2002 ◽  
Vol 19 (2) ◽  
pp. 149-151 ◽  
Author(s):  
Eron D. Crouch ◽  
Tahir Tak

1995 ◽  
Vol 130 (5) ◽  
pp. 1126-1127 ◽  
Author(s):  
Chittur A. Sivaram ◽  
Terrance Khastgir ◽  
Sharon L. Saneman ◽  
Ronald C. Elkins

2006 ◽  
Vol 102 (2) ◽  
pp. 378-379 ◽  
Author(s):  
Christopher B. Komanapalli ◽  
Uttam Tripathy ◽  
Mitchell Sokoloff ◽  
Siamak Daneshmand ◽  
Asish Das ◽  
...  

2020 ◽  
Vol 22 (3) ◽  
pp. 149-153
Author(s):  
N. A. Ognerubov ◽  
T. S. Antipova ◽  
G. E. Gumareva

Renal cell cancer metastases without evidence of a primary tumor are extremely rare. These variants are usually showed as a spontaneous description of single clinical cases. Aim.This contribution is a clinical follow-up of synchronous renal cell cancer metastases of unknown primary site. Results.A 52-year-old patient U. with a history of increased blood pressure, up to 170/100 mmHg for the last 5 years, who had undergone many instrumental examinations, including ultrasound examination, because of this disease. The computed tomography of the abdomen showed a 4975 mm heterogeneous tumor in the right adrenal gland in October 2017. The combined positron emission and X-ray computed tomography showed a 795441 mm mass in the right adrenal gland, associated with elevated fluorodeoxyglucose metabolic activity SUVmax 7.25. Focal accumulation of the radiopharmaceutical SUVmax 4.31 in a 171124 mm mass was detected in the space of bifurcation in the mediastinum. The lytic lesion (1015 mm) was found in right superior L3 articular process. The patient underwent retroperitoneoscopic adrenalectomy and thoracoscopic removal of mediastinal tumor in November 2017 because of the oligometastatic nature of the process. The histological study identified clear-cell carcinoma with areas of papillary structure in the right adrenal gland. The immunohistochemical study showed carcinoma cells intensively expressing CD10, and some other cells RCC. The immune phenotype of the tumor was identified as clear-cell renal cell carcinoma. The immunohistological and immunohistochemical analysis reviled the metastases of the same variant of renal cell carcinoma in one of 9 lymph nodes. The patient was treated with pazopanib. The primary renal tumor was not detected during the dynamic observation, including the application of annual combined positron emission and X-ray computed tomography. The patient is alive without disease progression with a follow-up of 32 months. Conclusion.Metastases of clear-cell renal cell carcinoma, including adrenal gland, without evidence of a primary site are extremely rare. The main method of treatment is a combination of surgery and targeted therapy, providing long-term local control of the course of the disease.


2015 ◽  
Vol 5 (5) ◽  
pp. 29607 ◽  
Author(s):  
Ahmad Al-Fakhouri ◽  
Inyong Hwang ◽  
Shadwan F. Alsafwah

2006 ◽  
Vol 119 (22) ◽  
pp. 1934-1936 ◽  
Author(s):  
Hai JIANG ◽  
Zhi-gen ZHANG ◽  
Zhao-dian CHEN ◽  
Shi-fang SHI ◽  
Song-liang CAI ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document